Publicacions

Gabriel R, Muñiz J, Vega S, Moral I, Pérez Castro TR, Rodriguez-Salvanés F, Suárez C, Novella B, Brotons C; EPICARDIAN Study Group. Cardiovascular risk in the elderly population of Spain. The EPICARDIAN risk score. Rev Clin Esp (Barc). 2021 Sep 24:S2254-8874(21)00150-8. doi: 10.1016/j.rceng.2021.05.003. Epub ahead of print. PMID: 34565710.

Brotons C, Moral I, González J, Fernández D, Puig M, Vilella MT. Epidemiology of hypertriglyceridaemia. Clin Investig Arterioscler. 2021 May;33 Suppl 2:7-13. English, Spanish. doi: 10.1016/j.arteri.2020.12.015. PMID: 34006358.

Grigorian-Shamagian L, Edel K, Esteve-Pastor MA, Aceña Á, Silva C, Delgado-Silva J, Ntaios G, Demerouti E, Brotons C. Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe. Front Cardiovasc Med. 2021 Aug 24;8:663361. doi: 10.3389/fcvm.2021.663361. PMID: 34504874; PMCID: PMC8421768.

Brotons C, Moral I, Fernández D, Puig M, Vilella MT, Puig T, Cuixart L, Férriz G, Pedro AM, Codinachs R, Rodríguez M, Fuentes R, On Behalf Of Inforisk Study Investigators. Effectiveness of an Intervention Aimed at Improving Information for Patients with High Cardiovascular Risk: INFORISK Clinical Trial. Int J Environ Res Public Health. 2021 Mar 31;18(7):3621. doi: 10.3390/ijerph18073621. PMID: 33807285; PMCID: PMC8036291.

Fernández-Cidón B, Candás-Estébanez B, Gil-Serret M, Amigó N, Corbella E, Rodríguez-Sánchez MÁ, Padró-Miquel A, Brotons C, Hernández-Mijares A, Calmarza P, Jarauta E, Brea AJ, Mauri M, Guijarro C, Vila À, Valdivielso P, Corbella X, Pintó X. Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study. J Clin Med. 2021 Mar 29;10(7):1379. doi: 10.3390/jcm10071379. PMID: 33805580; PMCID: PMC8037702

Armario P, Brotons C, Elosua R, Alonso de Leciñana M, Castro A, Clarà A, Cortés O, Díaz Rodriguez Á, Herranz M, Justo S, Lahoz C, Pedro-Botet J, Pérez Pérez A, Santamaria R, Tresserras R, Aznar Lain S, Royo-Bordonada MÁ. Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines. Clin Investig Arterioscler. 2021 Mar-Apr;33(2):85-107. English, Spanish. doi: 10.1016/j.arteri.2020.11.004. Epub 2021 Jan 22. PMID: 33495044

Moragas A, Garcia-Sangenís A, Prats Escudero A, Bayona Faro C, Hernández Ibáñez R, Brotons C, Vilella T, Puig M, Freixedas Casaponsa R, Cobo Guerrero S, Pera H, van der Velden AW, Butler CC, Llor C. Prevalencia de gripe confirmada microbiológicamente en pacientes con síntomas gripales en atención primaria y características clínicoepidemiológicas [Prevalence of microbiologically-confirmed influenza in patients with influenza-like illness in primary care and clinical and epidemiological characteristics]. Rev Esp Quimioter. 2021 Jun 13:moragas13jun2021. Spanish. doi: 10.37201/req/032.2021. Epub ahead of print. PMID: 34118801.

Moral Peláez, I., Brotons Cuixart, C., Fernández Valverde, D., Puig Palma, M., Calvo Bonacho, E., Martínez Muñoz, P., Catalina Romero C., Quevedo Aguado, L. J. (2021). External validation of the European and American equations for calculating cardiovascular risk in a Spanish working population. Revista Clinica Espanola.

Blancafort Alias S, Monteserín Nadal R, Moral I, Roqué Fígols M, Rojano I Luque X, Coll-Planas L. Promoting social capital, self-management and health literacy in older adults through a group-based intervention delivered in low-income urban areas: results of the randomized trial AEQUALIS. BMC Public Health. 2021 Jan 7; 21(1):84. doi: 10.1186/s12889-020-10094-9. PMID: 33413233; PMCID: PMC7791739.

Brotons C. Healthy habits and risk factors of parents can have long-term clinical consequences in their offspring. Eur J Prev Cardiol. 2020 Nov 25:zwaa111. doi: 10.1093/eurjpc/zwaa111. Epub ahead of print. PMID: 33624077

Piepoli M.F., Abreu A., Albus C., Ambrosetti M., Brotons C., Catapano A.L., et al., Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology* (2020) EUR J PREV CARDIOL, 27 (2), 181-205, IF:5.8640

Armario P, Brotons C, Elosua R, Alonso de Leciñana M, Castro A, Clarà A, Cortés O, Díaz Rodriguez Á, Herranz M, Justo S, Lahoz C, Pedro-Botet J, Pérez Pérez A, Santamaria R, Tresserras R, Aznar Lain S, Royo-Bordonada MÁ. Comentario del CEIPV a la actualización de las Guías Europeas de Prevención Vascular en la Práctica Clínica [Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Cardiovascular Prevention Guidelines.]. Rev Esp Salud Publica. 2020 Sep 11;94:e202009102. Spanish. PMID: 32915170.

Montenegro P, Brotons C, Serrano J, Fernández D, Garcia-Ramos C, Ichazo B, Lemaire J, Moral I, Wienese RP, Pitarch M, Puig M, Vilella MT, Sellarès J. Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain. Fam Pract. 2020 Sep 11:cmaa096. doi: 10.1093/fampra/cmaa096. Epub ahead of print. PMID: 32914857; PMCID: PMC7797756.

Brotons C. EUROPREV (Red Europea de Prevención y Promoción de la Salud) [EUROPREV (European Network for Prevention and Health Promotion)]. Aten Primaria. 2020 Nov;52 Suppl 2(Suppl 2):3-4. Spanish. doi: 10.1016/j.aprim.2020.07.005. PMID: 33388115; PMCID: PMC7801224.

Montalescot G, Brotons C, Cosyns B, Crijns HJ, D’Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators. Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial. Am J Cardiovasc Drugs. 2020 Feb;20(1):61-71. doi: 10.1007/s40256-019- 00356-2. PMID: 31243691; PMCID: PMC6978445.

• Fernández D, Brotons C, Moral I, Bulc M, Afonso M, Akan H, Pinto S, Vucak J, da Silva Martins CM. Lifestyle behaviours in patients with established cardiovascular diseases: a European observational study. BMC Fam Pract. 2019 Nov 26;20(1):162. doi: 10.1186/s12875-019-1051-3.
• Bertomeu-González V, Soriano Maldonado C, Bleda-Cano J, CarrascosaGonzalvo S, Navarro-Perez J, López-Pineda A, Carratalá-Munuera C, Gil Guillén VF, Quesada JA, Brotons C, Orozco-Beltrán D. Predictive validity of the risk SCORE model in a Mediterranean population with dyslipidemia. Atherosclerosis. 2019 Nov;290:80-86. doi: 10.1016/j.atherosclerosis.2019.09.007. Epub 2019 Sep 23.
• Johnston BC, Zeraatkar D, Han MA, Vernooij RWM, Valli C, El Dib R, Marshall C, Stover PJ, Fairweather-Taitt S, Wójcik G, Bhatia F, de Souza R, Brotons C, Meerpohl JJ, Patel CJ, Djulbegovic B, Alonso-Coello P, Bala MM, Guyatt GH. Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium. Ann Intern Med. 2019 Oct 1. doi: 10.7326/M19-1621.
• Montalescot G, Brotons C, Cosyns B, Crijns HJ, D’Angelo A, Drouet L, Eberli F, Lane DA, Besse B, Chan A, Vicaut E, Darius H; AEGEAN Study Investigators. Educational Impact on Apixaban Adherence in Atrial Fibrillation (the AEGEAN STUDY): A Randomized Clinical Trial. Am J Cardiovasc Drugs. 2019 Jun 26. doi: 10.1007/s40256-019-00356-2.
• Cainzos-Achirica M, Fedeli U, Sattar N, Agyemang C, Jenum AK, McEvoy JW, Murphy JD, Brotons C, Elosua R, Bilal U, Kanaya AM, Kandula NR, Martinez-Amezcua P, Comin-Colet J, Pinto X. Epidemiology, risk factors, and opportunities for prevention of cardiovascular disease in individuals of South Asian ethnicity living in Europe. Atherosclerosis. 2019 Jul;286:105- 113. doi: 10.1016/j.atherosclerosis.2019.05.014. Epub 2019 May 16.

• Castera P, Stewart E, Großkopf J, Brotons C, Brix Schou M, Zhang D, Steiniger Brach B, Meulien D; on behalf of the PICASO Study Investigators. Nalmefene, Given as Needed, in the Routine Treatment of Patients with Alcohol Dependence: An Interventional, Open-Label Study in Primary Care. Eur Addict Res. 2018;24(6):293-303. doi: 10.1159/000494692. Epub 2018 Nov 28.
• Gaziano JM, Brotons C, Coppolecchia R, Cricelli C, Darius H, Gorelick PB, Howard G, Pearson TA, Rothwell PM, Ruilope LM, Tendera M, Tognoni G; ARRIVE Executive Committee. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet. 2018 Sep 22;392(10152):1036-1046. doi: 10.1016/S0140-6736(18)31924-X. Epub 2018 Aug 26.
• Brotons C. EUROPREV (European Network for Prevention and Health Promotion). Aten Primaria. 2018 May;50 Suppl 1:3.
• Guillén-Gómez E, Bardají-de-Quixano B, Ferrer S, Brotons C, Knepper MA, Carrascal M et al. Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy. J Diabetes Res. 2018 Apr 29;2018:6165303. doi: 10.1155/2018/6165303. eCollection 2018.
• Pedro-Botet J, Rodríguez-Padial L, Brotons C, Esteban-Salán M, García-Lerín A, Pintó X, Lekuona I, Ordóñez-Llanos J. The Ideal Lipid Report: A Need for Consensus. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):512-514
• de Gonzalo-Calvo D, Vea A, Bär C, Fiedler J, Couch LS, Brotons C, Llorente-Cortes V, Thum T. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine? Eur Heart J. 2018 Apr 24. doi: 10.1093/eurheartj/ehy234.
• Pedro-Botet J, Rodríguez-Padial L, Brotons C, Esteban-Salán M, García-Lerín A, Pintó X, Lekuona I, Ordóñez-Llanos J. Homogenization of the lipid profile values. Clin Investig Arterioscler. 2018 Jan – Feb;30(1):36-48.
• Brotons C, Moral I, Fernández D, Puig M, Calvo E, Martínez P, Catalina C, Quevedo LJ. Estimación del riesgo cardiovascular de por vida: una herramienta nueva en prevención primaria de las enfermedades cardiovasculares (IBERLIFERISK). Rev Esp Cardiol 2018.
• Illamola L, Rodríguez J, Alonso-Villaverde C, Salvador-González B, Moral I. Efectos a largo plazo de uma intervención intensiva sobre cambios en los estilos de vida en pacientes con hiperfibrinogenemia y riesgo cardiovascular moderado-alto. Aten Primaria 2018; 50(6): 325-31.
• Brotons C, Fernández D, Moral I. Factores de riesgo cardiovascular emergentes frente a clásicos. Diabetes Práctica 2018; 9(1); 10
• Piepoli MF, Hoes AW, Brotons C, Hobbs RFD, Corra U; Task Force for the 2016 guidelines on cardiovascular disease prevention in clinical practice. Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur J Gen Pract. 2018 Dec;24(1):51-56
• Rehm J, Anderson P, Prieto JAA, Armstrong I, Aubin HJ, Bachmann M, Bastus NB, Brotons C et al. Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European Union. BMC Med. 2017 Sep 28;15(1):173

• Ruiz Morilla MD, Sans M, Casasa A, Giménez N. Implementing technology in healthcare: insights from physicians. BMC Med Inform Decis Mak. 2017 Jun 27;17(1):92.
• Godycki-Cwirko M, Panasiuk L, Brotons C, Bulc M, Zakowska I. Perception of preventive care and readiness for lifestyle change in rural and urban
  patients in Poland: a questionnaire study. Ann Agric Environ Med. 2017 Dec 23;24(4):732-738.
• Marquez-Contreras E., Martell-Claros N., Gil-Guillen V., De la Figuera-Von Wichmann M., Sanchez-Lopez E., Gil-Gil I., Marquez-Rivero S., Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance (2017) Qual Life Res 2017; 26 (3): 647-54.
• Coll-Planas L, Monteserín R, Cob E, Blancafort S. What are primary health care teams doing about loneliness?. Fundació Salut i Envelliment-Universitat Autònoma de Barcelona i EAP Sardenya- Barcelona. Aten Primaria. 2017 Oct;49(8):501-502
• Coll-Planas L, Nyqvist F, Puig T, Urrútia G, Solà I, Monteserín R. Social capital interventions targeting older people and their impact on health: a systematic review. Fundació Salut i Envelliment, Universitat Autònoma de Barcelona, Universitat Autònoma de Barcelona, Institute of Biomedical Research (IIB Sant Pau), Faculty of Education and Welfare Studies, Social Policy, Åbo Akademi University, Vaasa, Finland, Servicio de Epidemiología Clínica y Salud Pública, Hospital de la Santa Creu i Sant Pau, CIBER de Epidemiología y Salud Pública (CIBERESP) Madrid i Equip d’Atenció Primària Sardenya, EAP Sardenya, Barcelona, Spain. J Epidemiol Community Health. 2017 Jul;71(7):663-672.
• Royo-Bordonada M.A., Armario P., Lobos Bejarano J.M., Pedro-Botet J., Villar Alvarez F., Elosua R., Brotons Cuixart C., Cortes O., Serrano B., Camafort Babkowski M., Gil Nunez A., Perez A., Maiques A., de Santiago Nocito A., Castro A., Alegria E., Baeza C., Herranz M., Sans S., Campos P., Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice Adaptación española de las guías europeas de 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica (2017) Gac Sanit 2017; 31 (3): 255-26.
• F. López-Simarro, I. Moral, A. Aguado-Jodar, C. Cols-Sagarra, J. Mancera-Romero, M. Alonso-Fernández, S. Miravet-Jiménez, y C. Brotons. Impacto de la inercia terapéutica y del grado de adherencia al tratamiento en los objetivos de control en personas con diabetes. Semergen. 2017.
• Aguilà Q, Ramón MA, Matesanz S, Vilatimó R, Moral I, Brotons C, Ulied A. Estudio de la valoración del estado nutricional y los hábitos alimentarios y de actividad física de la población escolarizada de Centelles, Hostalets de Balenyà y Sant Martí de Centelles (Estudio ALIN 2014). Endocrinología, Diabetes y nutrición. 2017; 64 (2)
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]. G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612
• Brotons Cuixart C., Lobos Bejarano J.M., New European guidelines for cardiovascular prevention and its Spanish adaptation Nuevas guías europeas de prevención cardiovascular y su adaptación española (2017) Aten Prim 2017; 49 (4): 201-203.
• Calvo-Bonacho E, Catalina-Romero C, Cabrera M, Fernández-Labandera C, Sánchez Chaparro MÁ, Brotons C, Ruilope LM. Association Between Improvement in Cardiovascular Risk Profile and Changes in Sickness Absence: Results of the ICARIA Study. Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):941-951
• Coll-Planas L., del Valle Gomez G., Bonilla P., Masat T., Puig T., Monteserin R., Promoting social capital to alleviate loneliness and improve health among older people in Spain (2017) Health Soc Care Comm 2017; 25 (1): 145-157

• Carme Alviraa, Sofía Berlangab, Carme Chamarroc, Carme Graboledad, Angels Larrabeitie, Carme Marquillesf, Montse Ramblag, Montse Sallésh, Montse Saumelli, Encarnació Torj, Judit Vila. Implementación de las Unidades Docentes Multiprofesionales de Atención Familiar y Comunitaria en Cataluña. Revista Atención Primaria. Eselvier, Volum 48, Número 9, Novembre de 2016.
• Brotons C, Moral I, Fernández D, Cuixart L, Muñoz A, Soteras A, Puig M, Joaniquet X, Casasa A. Consecuencias clínicas de la utilización de las nuevas tablas de riesgo cardiovascular SCORE OP para pacientes mayores de 65 años. Med Clin 2016; 147 (9): 381-386.
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Richard Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Monique Verschuren WM. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Verschuren WM. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis. 2016 Sep;252:207-74
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM, Binno S. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Kardiol Pol. 2016;74(9):821-936
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Additional Contributor: Simone Binno (Italy); Document Reviewers:, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 2016 Jun 27.
• Brotons C. EUROPREV (European Network for Prevention and Health Promotion). Aten Primaria. 2016 Jun;48 Suppl 1:3. doi: 10.1016/S0212-6567(16)30184-6. Review.
• Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 May 23. pii: ehw106.

• Brotons C, Calvo-Bonacho E, Moral I, Puig M, Garcia-Margallo MT, Cortés-Arcas MV, Catalina-Romero C, Quevedo-Aguado L, Ruilope LM. Comparison of application of different methods to estimate lifetime cardiovascular risk. Eur J Prev Cardiol. 2015 Mar 31. pii: 2047487315579616.
• Brotons C, Benamouzig R, Filipiak KJ, Limmroth V, Borghi C. A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs. 2015 Apr;15(2):113-33
• Benitez-Camps M, Vinyoles-Bargallo E, Re­bagliato-Nadal O, Morros-Pedros R, Pera-Pujadas H, Dalfo-Baque A, Lo­pez-Pavon I, Roca-Sanchez C, Coma-Carbo RM, De La Figuera Von Wichmann M, Men­gual-Martinez L, Yuste-Marco C, Teixido-Co­let M, Pepio i Vilaubi JM, Ciurana-Tost R, Pou-Vila R, Vila-Coll MA, Bordas-Julve JM, Aragones-Fores R, Pelegrina-Rodriguez FJ, Agudo-Ugena J, Blanco-Mata C, de la Igle­sia Berrojalbiz J, Burgos-Alonso N, Go­mez-Fernandez MC. Evaluation of the rela­tionship between effervescent paracetamol and blood pressure: Clinical trial. (2015) BMC CARDIOVASC DISOR, 15 (1).
• Carratala-Munuera C, Gil-Guillen VF, Oroz­co-Beltran D, Maiques-Galan A, Lago-Deibe F, Lobos-Bejarano JM, Brotons-Cuixart C, Martin-Rioboo E, Alvarez-Guisasola F, Lo­pez-Pineda A. Barriers to improved dyslipid­emia control: Delphi survey of a multidisci­plinary panel. (2015) FAM PRACT, 32 (6), 672-680.
• Coll-Planas L, del Valle Gomez G, Bonilla P, Masat T, Puig T, Monteserín R, Promoting social capital to alleviate loneliness and im­prove health among older people in Spain. (2015) HEALTH SOC CARE COMM.
• Gabriel R, Brotons C, Tormo MJ, Segura A, Rigo F, Elosua R, Carbayo JA, Gavrila D, Moral I, Tuomilehto J, Muniz J, The ER­ICe-score: The new native cardiovascular score for the low-risk and aged Mediterra­nean population of Spain. (2015) REV ESP CARDIOL, 68 (3), 205-215.
• Lobos Bejarano JM, Brotons Cuixart C, Galve E, Royo-Bordonada MA, Alegria Ezquerra E, Armario P, Camafort Babkowski M, Cordero Fort A, Maiques Galan A, Man­tilla Morato T, Perez Perez A, Pedro-Botet J, Villar Alvarez F, Gonzalez-Juanatey JR. Spanish Interdisciplinary Committee for Car­diovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines. (2015) REV ESP SALUD PUBLIC, 89 (1), 15-26.
• Perez A, Roque M, Domenech S, Montese­rín R, Soriano N, Blancafort X, Bosom M, Vidal C, Petit M, Hortal N, Gil C, Espelt A, Lopez MJ. Efficacy of memory training in healthy community-dwelling older people: Study protocol for a randomized controlled trial. (2015) BMC GERIATR, 15 (1).
• Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasen­fuss G, Kjeldsen K, Lancellotti P, Landmess­er U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, Gaemperli O, Achenbach S, Agewall S, Badimon L, Bai­gent C, Bueno H, Bugiardini R, Carerj S, Casselman F, Cuisset T, Erol C, Fitzsimons D, Halle M, Hamm C, Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GYH, Piepoli MF, Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Zamorano JL. Guía ESC 2015 sobre el tratamiento de los síndromes coronarios agudos en pacien­tes sin elevación persistente del segmento ST: Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) para el tratamiento de los síndromes coronarios agudos en pacien­tes sin elevación persistente del segmento ST. (2015) REV ESP CARDIOL, 68 (12), 1125e1- 1125e64.
• Vinyoles E, Soldevila N, Torras J, Olona N, de la Figuera M. Prognostic value of non-specific ST-T changes and left ventricu­lar hypertrophy electrocardiographic crite­ria in hypertensive patients: 16-year fol­low-up results from the MINACOR cohort. (2015) BMC CARDIOVASC DISOR.
• Cuixart Costa, L. Palpitaciones. Actualización en Medicina de Familia. AMF 2015; 11(1):24-39.
• Moreno Ripoll, F. Radiologia Osteoarticular no traumática. Monogràfic. AMF. Novembre 2015.
• Moreno Ripoll, F; Madueño Garro, C. Radiologia Osteoarticular no traumàtica. Actualización en Medicina de Familia. AMF 2015; Volum 11, Número 10, 551-602.
• Implementación de las UDM de Atención Familiar y Comunitaria en Cataluña. APRIM-OA-13-787 Atención Primaria. Participació Judith Vila.
• Elaboració i publicació de receptes per a diabètics en “El libro de las recetas ‘Método del plato’”. Roche 2015. Judith Vila.
• Puentes Torres RC, et al. Aceptabilidad de la búsqueda oportunista de la infección por el virus de la inmunodeficiencia humana mediante serologia en pacientes captados en centros de atención primaria de España. Estudio VIH-AP. Aten Primaria. 2015. Joan Josep Gil.

• Mortsiefer A, Ludt S, Pentzek M, Wilm S, Brotons C. Patients’ Needs and Expectations Concerning Prevention and Health Advice in Primary Care. Results from the EUROPREVIEW Survey. Gesundheitswesen. 2014 Jul;76(7):417-22.  (en alemany)
• Gabriel R, Brotons C, Tormo MJ, Segura A, Rigo, Elosua R et al on behalf of the ERICE Study Group. La ecuación ERICE: primera ecuación autóctona de riesgo cardiovascular para una población mediterránea envejecida y de bajo riesgo en España. Rev Esp Cardiol. 2014 Aug 21. pii: S0300-8932(14)00313-3. doi: 10.1016/j.recesp.2014.03.019. [Epub ahead of print] English, Spanish. (FI 2013: 3,204)
• Monteserín Rosa, Roberts Helen Clare, Sayer Avan Aihie. Papel de los profesionales de la atención primaria en el manejo de la sarcopenia. Role of primary care professionals in the management of sarcopenia. EAP Sardenya-IIB Sant Pau, Barcelona. Academic Geriatric Medecine, University of Southampton, Southampton, United Kingdom, MRC Lifecourse Epidemiology Unit. Atención Primaria 11/2014; Volume 46(9):455-456
• Moreno Ripoll F, Forcada Gosbert J, Madueño Garro C. Lumbalgia. AMF 2014; 10(1):4-11
• Brotons C, Calvo-Bonacho E, Moral I, Garcia-Margallo MT, Cortés-Arcas MV, Puig M et al. Impacto de las nuevas guías americanas y británicas en el manejo y tratamiento de las dislipemias en una población laboral española. Rev Esp CArdiol 2014.  10.1016/j.recesp.2014.06.020
• Brotons C, Moral I, Soriano N, Cuixart L, Osorio D, Bottaro D, Puig M, Joaniquet X, Marcos A, Casasa, A. Impacto de la utilización de las diferentes tablas SCORE en el cálculo del riesgo cardiovascular. Rev. Esp. Cardiol. 2014; 67 (2) 94-100
• Bordas Julve JM, Forcada Gisbert J, Moreno Ripoll F.. Atención Primaria. Conceptos, organización y pràctica clínica. Cap. 50. Patología osteoarticular. 7a Ed. 2014. ISBN: 9788490228678
• Botella Tomás M, Faci Moreno C. Pseudoquiste pancreàtic. Butlletí de la Medicina de Família a Catalunya. Butlletí: Vol 31:Iss 1, Article 5.

• Márquez-Contreras E, Gil-Guillén VF, De la Figuera-Von Wichmann M, Franch-Nadal J, Llisterri-Caro JL, Martell-Claros N, Martin-De Pablos JL, Casado-Martinez JJ, Bertomeu-Gonzalez V, Pertura-Martinez S, Carratalá-Munuera C, Orozco-Beltrán D, López-Pineda A; Working Group on Non-compliance and Inertia, Spanich Society of Hypertension (SHE-LELHA). Curr Med Res Opn. 2013 Oct 17. Non-compliance and inertia in hypertensive Spaniards at high cardiovascular risk: CUMPLE study.
• Ramírez de Arellano A, Coca A, de la Figuera M, Rubio-Terrés C, Rubio-Rodríguez D, Gracia A, Boldeanu A, Puig-Gilberte J, Salas E. Appl Health Econ Health Policy. 2013 Oct; 11(5):531-42 Economic evaluation of cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment.PMID: 22587668 PubMed
• Fernández Valverde D, Muñoz Pena A. AINE y riesgo cardiovascular en postinfartados. AMFj2013;2(4):2
• Lobos Bejarano JM, del Castillo-Rodriguez JC, Mena-Gonzalez A, Alemán Sánchez JJ, Cabrera de León A, Barón-Esquivias G, Pastor-Fuentes A, en nombre de los investigadores del Estudio FIATE (Situación actual de la FIbrilación auricular en ATención primaria en España). Características de los pacientes y abordaje terapéutico de la fibrilación auricular en atención primaria en España: Estudio FIATE. Medicina clínica .Vol. 141. Núm. 04. Agosto 2013.
• Características de los pacientes y abordaje terapéutico de la fibrilación auricular en atención primaria en España: Estudio FIATE. Medicina clínica .Vol. 141. Núm. 04. Agosto 2013.
• Hermans MP, Elisaf M, Michel G, Muls E, Nobels F, Vandenberghe H, Brotons C; for the OPTIMISE (OPtimal Type 2 dIabetes Management Including benchmarking and Standard trEatment) International Steering Committee. Benchmarking Is Associated With Improved Quality of Care in Type 2 Diabetes: The OPTIMISE randomized, controlled trial. Diabetes Care. 2013 Jul 11. [PMID: 23846810]
• Brotons C, Lobos JM, Royo-Bordonada MA,  Maiques  A, de Santiago  A, Castellanos  Á, Diaz  S, Obaya CJ, Pedro-Botet  J, Moral  I, Lizarbe  V, Moreno  R, Pérez  A, Cordero  A, Fornés-Ubeda  F, Serrano-Saiz  B, Camafort-Babkowski  M, Elosua  R, Sans  S, de Pablo  C, Gil-Nuñez  A, de Álvaro-Moreno  F, Armario  P, Rico Cortés O, Villar  F, Lizcano Á . Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care. BMC Family Practice. 2013, 14:36 doi:10.1186/1471-2296-14-36.(FI 1,80).
• La prevención de la enfermedad tromboembólica venosa. Actualización en Medicina de família. Volumen 9, nº 2 (Febrer 2013).
• Ledesma, Albert. “ The role of nursing in the self – manangement system “ Vol . 3 nº 12  – JNEP. Any 2013.
• Royo-Bordonada MA, Lobos Bejarano JM, Villar Alvarez F,  Sans S, Perez A, Pedro-Botet J, Moreno Carriles RM,  Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C,  Álvaro Moreno F, Cortés O, Cordero A,Camafort Babkowski M, Brotons Cuixart C, Armario P, en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC). Comentarios del comité español interdisciplinario de prevención cardiovascular (ceipc) a las guías europeas de prevención cardiovascular. 2012 Rev Esp Salud Pública 2013; 87:103-120. (FI 0.774).
• Reyes C, Formiga F, Coderch M, Hoyo J, Ferriz G, Casanovas J, Monteserín R, Brotons C, Rojas M, Moral I. Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region. Bone 2013; 52(2): 557-61. (FI 4.023).
• Royo-Bordonada MA, Lobos JM, Brotons C, Villar F, de Pablo C, Armario P, Cortés O, Gil Nuñez A, Lizcano A, de Santiago A, Sans S; en nombre del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC). El estado de la prevención cardiovascular en España. Med Clin (Barc). 2013 Feb 21. doi:pii: S0025-7753(13)00015-8. (FI 1,231).

• Brotons C. Los nuevos marcadores de riesgo cardiovascular: ¿de dónde venimos, dónde estamos, hacia dónde vamos?. Clin Invest Arterioescl. 2012; 24 (2): 89-91.
• Brotons C, Drenthen AJM, Durrer D, Moral I.On behalf of European Network on Prevention and Health Promotion (EUROPREV). Beliefs and atitudes to lifestyle, nutrition and physical activity: the views of patients in Europe. Family practice 2012; 9 (suppl1):i168-i176.
• Ledesma, Albert. ¿Autogestión o autonomía de gestión? Informe SESPAS 2012 Ga. Sanitaria 2012;26(S):57-62. Elsevier – Any 2012.
• De la Figuera M, Fernández J, Fernández MI, Castelló M, Canades J; Suitability and performances of echocardiogram in primary care. ARECO. Aten Primaria. 2012 Apr;44(4):190-8. Doi:10.1016/j.aprim.2011.03.007. Epub 2011 Sep 19. Spanish.
• Variability and concordance of Cornell and Sokolow-Lyon electrocardiographic criteria in hypertensive patients. Vinyoles E, Rodriguez-Blanco T, de la Figuera M, Colomé JM, Tafalla M, Calbet N, Fernández-San Martín MI, García-Alonso J, Murillo C, Agudo J. Bood Press. 2012 Dec;21(6):352-9. doi:10.3109/08037051.2012.686180.Epb 2012 May 16. PMID: 22587668 
• Brotons C, Lobos JM, Royo-Bordonada MA,  Maiques  A, de Santiago  A, Castellanos  Á, Diaz  S, Obaya CJ, Pedro-Botet  J, Moral  I, Lizarbe  V, Moreno  R, Pérez  A, Cordero  A, Fornés-Ubeda  F, Serrano-Saiz  B, Camafort-Babkowski  M, Elosua  R, Sans  S, de Pablo  C, Gil-Nuñez  A, de Álvaro-Moreno  F, Armario  P, Rico Cortés O, Villar  F, Lizcano Á . Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care. BMC Family Practice. 2013, 14:36 doi:10.1186/1471-2296-14-36.(FI 1,80).
• Mª Victoria Mazo Ancochea en la redacció de la Guia de Salut Mental i Atenció Primària de la Camfic.201
• Patients with atrial fibrillation in a primary care setting: Val-FAAP study. Barrios V, Calderón A, Escobar C, de la Figuera M; Primary Care Group in the Clinical Cardiology Section of the Spanish Society of Cardiology. Ver Esp Cardiol (Engl Ed). 2012 Jan;65(5):494. PMID: 22054913 
• Eddy Ives LS, Moral Pelaez I, Brotons Cuixart C, de Frutos Gallego E, Calvo Terrades M, Curell Aguila H. Hábitos de estilo de vida en adolescentes con sobrepeso y obesidad (Estudio Obescat). Rev. Pediatr Aten Primaria 2012; 14:127-37.
• Ferreira-Gonzalez N, Pinar-Sopena J, Ribera A, Marsal JR, Cascant P, Gonzalez-Alujas, Evangelista A, Brotons C, Moral I, Permanyer-Miralda G, Garcia Dorado D, Tornos P. Prevalence of calcific aortic valve disease in the elderly and assocoated risk factors: a population-based study in a Mediterranean area. Eur J Prev Cardiol 2012.
• Hermans MP, Brotons C, Elisaf M, Michel G, Muls E, Nobels F. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchamarking study: baseline results form six European countries. Eur J Prev Cardiol 2012.
• Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD et al; ALTITTUDE Investigators (Brotons C as co-author). Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Eng J Med 2012; 367 (23): 2204-13.
• López Simarro F, Brotons C, Moral I, Cols Sagarra C, Selva A, Aguado-Jodar A, Miravet-JIménez S. Inercia y cumplimiento terapéutico en pacientes con Diabetes Mellitus tipo 2 en atención primaria. Med Clin (Barc). 2012; 138 (9): 377-84.
• De la Figuera, Mariano; Fernández, Jordi; Fernández, María Isabel; Castelló, Marta; Canadell, Josepa. Adecuación y rendimiento del ecocardiograma en atención primaria. Aten Primaria. 2012;44:190-8. – vol.44 núm 04.
• Brotons C, Bulc M, Sammut M, Sheehan M, da Silva Martins CM, Björkelund C, Drenthen A, Duhot D, Gorpelioglu S, Jurgova E, Keinanen-Kiukkanniemi S, Kotányi P, Markou V, Moral I, Mortsiefer A, Pas L, Pichler I, Sghedoni D, Tataradze R, Thireos E, Valius L, Vuchak J, Collins C, Cornelis E, Mierzecki A, Nadaraia K, Godycki-Cwirko M. Attitudes toward preventive services and lifestyle: the viewsof primary care patients in Europe. The EUROPREVIEW patient study. Family practice 2012; 29 (suppl1): i49-i55.
• De la Figuera, M. Pacientes con fibrilación auricular asistidos en consultas de AP. Estudio Val – FAAP. Eselvier España. Sociedad Española de Cardiología. 2012; 65:47-53.
• Esther Vilert Garrofa. Caps d’Estudi de les UUDD de Medicina de Família i Comunitària de Catalunya. (2012).Protocol de supervisió i nivell de responsabilitat dels residents de medicina familiar i comunitària en les urgències hospitalàries. Butlletí: Vol 30:Iss 1, Article 5.
• De la Figuera, M. New evidence, New Controversies: a Critical Review of European Society of Cardiology ’10 Clinical Practice guidelines on Atrial Fibrilation. Revista Española de Cardiología. 2012:65 (1):7-13
• Brotons C, Soriano N, Moral I, Rodriguez-Artalejo F, Banegas JR, Martín JM. Actividades Preventivas y de Promoción de la Salud. Efectividad de las intervenciones en el ámbito de la Atención Primaria. Informe SESPAS 2012. Gaceta Sanitaria 2012; 26(S):151-157.
• Diaz-Buschmann I, Castro A, Galve E, Calero MJ, Dalmau R, Guzmán G, Cordero A, Fácila L, Quiles J, Arrarte V, Diaz-Buschmann I, Alonso Gómez ÁM, Cequier Á, Comín J, Fernández-Ortiz A, Pan M, Fernández Lozano FW, Fernández-Ortiz A, Sanmartín M, Ferreira I, Brotons C, López Sendón JL, Mazón P, Alonso J, Abeytua M, González Juanatey JR, de Pablo C, Worner F, Castro-Beiras A. Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed). 2012; 65(10): 869-73.
• Groene AO, Bolíbar I, Brotons C. Impact, barriers and facilitators of the “Ask Me 3” Patient Communication Intervention in a primary care center in Barcelona, Spain: a mixed-methods analysis. The international Journal of Person Centered Medicine 2012;2:853-861.
• Brotons C, Lobos JM, Martín E, Maiques A y por el grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS). Evidencias del tratamiento antiagregante. Recomendaciones PAPPS. Atención Primaria 2012; 44 (12):734-6
• Authors/Task Force Members:, Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte Op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; Other experts who contributed to parts of the guidelines:, Cooney MT; ESC Committee for Practice Guidelines (CPG):, Bax J, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers:, Funck-Brentano C, Sirnes PA, Aboyans V, Ezquerra EA, Baigent C, Brotons C, Burell G, Ceriello A, De Sutter J, Deckers J, Del Prato S, Diener HC, Fitzsimons D, Fras Z, Hambrecht R, Jankowski P, Keil U, Kirby M, Larsen ML, Mancia G, Manolis AJ, McMurray J, Pajak A, Parkhomenko A, Rallidis L, Rigo F, Rocha E, Ruilope LM, van der Velde E, Vanuzzo D, Viigimaa M, Volpe M, Wiklund O, Wolpert C. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2012 Jul;33(13):1635-701.
• New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrilation. Anguita M, Worner F, Domenech P, Marín F, Ortigosa J, Pérez-Villacastín J, Fernández-Ortiz A, Alonso A, Cequier A, Comín J, Heras M, Pan M, Alzueta J, Arenal A, Barón G, Borrás X, Bover R, de la Figuera M, Escobar C, Fiol M, Herreros B, Merino JL, Mont L, Murga N, Pedrote A, Quesada A, Ripoll T, Rodriguez J, Ruiz M, Ruiz R. Ver Esp Cardiol (Engl Ed). 2012 Jan;65(1):7-13.doi: 10.1016/j.recesp.2011.10.003. Epub 2011. Nov 17. Review. English, Spanish.
• Márquez-Contreras E, de la Figuera-Von Wichmann M, Franch-Nadal J, llisterrri-Caro JL, Gil-Guille´n V, Martín-de Pablos JL, Casado-Martínez JJ, Martell-Claros N. Do Patients With High Vascular Risk Take Antihypertensive Medication Correctly? Cumple-MEMS Study. Ver Esp Cardiol (Engl Ed). 2012 Jun;65(6):544-50.doi:10.1016/j.recesp.2012.01.018.Epub 2012 Apr 19.
• Luis Á Pérula-de-Torres et Al. Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primary care: a randomized clinical trial of efficacy. DOFA-AP Study-protocol. BMC Family Practice 2012, 13:106. Participants estudi Dofa.

• Gemma Férriz Villanueva, Marta Rojas Blanc, Natàlia Riera Nadal, Clara Riera Nadal, Francisco Javier Fernández Martínez. Qué gasto famacológico genera un diabético bien controlado? Aten Primaria. 2011; 43: 169-74.
• V. Liste. “Programa d´atenció coordinada per a la malaltia renal crònica (MRC)”. Servei de Nefrologia F Puigvert i EAPs dreta BCN. 2011.
• De la Figuera, M. Suitability and performance of echocardiogram in primary care. Elsevier España. AP 2011, Sep. 19.
• Cervera Leon, M. Carta al director. Antes y después del filtrado glomerular. Aten Primaria. 2011;43:561-vol 43 num 10.
• Cervera Leon, M. Carta al director. El tratamiento antidiabético inadecuado empeora el control de los pacientes diabéticos con insuficiencia renal crónica. Aten Primaria. 2011;43:107-8-vol 43.
• Brotons C, Soriano N, Moral I, Rodrigo M.P, Kloppe P, Rodríguez A.I, et-al. Ensayo clínico aleatorizado para evaluar la eficacia de un programa integral de prevención secundaria de las enfermedades cardiovasculares en atención primaria: estudio PREseAP. Rev Esp Cardiol. 2011; 64:13-20.
• Lobos Bejarano JM, Brotons Cuixart C. Factores de riesgo cardiovascular y atención primaria: evaluación e intervención. Aten Primaria, 2011; 43 (12): 668-77.
• Nobels F, Debacker N, Brotons C, Elisaf M, Hermans MP, Micher G, Muls E and the OPTIMISE (Optimal Type 2 Diabetes Management Including benchamarking and Standard treatment) International Steering Committee. Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus. Cardiovascular Diabetology 2011, 10:82.
• Brotons C, Elisaf M, Hermans M, Michel G, Muls E, Matthys A. Evaluating benchmarking to optimize management of type 2 diabetic patients: control of hypertension in the European OPTIMISE study. Journal of Hypertension 2011;29(e-Suppl A): e115–116.
• Brotons C, Bulc M, Sammut M , Sheehan M, da Silva Martins C M, Björkelund C, Drenthen A, Duhot D, Gorpelioglu S, Jurgova E, Keinanen-Kiukkanniemi S, Kotányi P, Markou V, Moral I, Mortsiefer A, Pas L, Pichler I, Sghedoni D, Tataradze R, Thireos E, Valius L, Vuchak J, Collins C, Cornelis E, Mierzecki A, Nadaraia K, Godycki-Cwirko M. Attitudes toward preventive services and lifestyle: the views of primary care patients in Europe. The EUROPREVIEW patient study. Family practice.
• Lopez Simarro F, Brotons C; Moral I, Cols-Sagarra C, Selva A, Aguado-Jodar A, Miravet-Jiménez S. Inercia y cumplimiento terapéutico en pacientes con Diabetes Mellitus tipo 2 en atención primaria. Med Clin (Barc). 2011.
• Litt J, Brotons C, Bulc M, Kloppe P, Pas L, Van Linden A et al. Putting prevention into practice – case studies from our countries. Primary Care 2011; 11(4): 63-65.